Voyager Therapeutics logo
Voyager Therapeutics VYGR
$ 5.8 2.29%

Quarterly report 2024-Q3
added 11-12-2024

report update icon

Voyager Therapeutics Operating Cash Flow 2011-2024 | VYGR

Annual Operating Cash Flow Voyager Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
77.9 M -12.5 M -53.5 M -96.7 M 48.7 M -15.9 M -61.4 M -42.5 M 41.3 M - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
77.9 M -96.7 M -12.7 M

Quarterly Operating Cash Flow Voyager Therapeutics

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
- - 58.8 M - - - 124 M - -265 K - 34.4 M - -64.7 M - -21.3 M - -74.7 M -50 M -28.8 M - 72 M 93.6 M 125 M - 8.46 M 26.1 M 48.6 M - -46.5 M -30.6 M -14.3 M - -29.4 M -19.2 M - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
125 M -74.7 M 10.5 M